Multiplexed immunobead‐based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival
- 29 November 2010
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 33 (6), 886-897
- https://doi.org/10.1002/hed.21557
Abstract
Background The purpose of this study was to examine cytokine profiles of peripheral blood for nasopharyngeal carcinoma (NPC). Methods A total of 132 patients with untreated NPC, 169 healthy individuals, and 32 patients with chronic rhinosinusitis (CRS) were enrolled in this study. The plasma levels of 13 cytokines were measured by the multiplexed immunobead‐based method. Results The levels of interleukin (IL)‐6, IL‐8, interferon‐inducible protein 10 (IP‐10), tumor necrosis factor (TNF)‐α, vascular endothelial growth factor (VEGF), and macrophage inflammatory protein (MIP)‐3α were significantly elevated in patients with NPC; but the stem cell factor (SCF) levels were significantly lower. The levels of IL‐6, IL‐8, IP‐10, and MIP‐3α were significantly elevated in patients with advanced stages disease and correlated with Epstein–Barr virus (EBV) DNA. A 2‐marker panel consisting of MIP‐3α and SCF increased the screening efficacy of EBV‐specific viral capsid antigen (VCA) IgA or EBV DNA, although the addition of MIP‐3α and SCF to the combined set of currently available markers (EBV VCA IgA and EBV DNA) did not improve the accuracy of the diagnostic panel. The patients with NPC with higher levels of IL‐8, VEGF, MIP‐3α, and EBV DNA had worse prognoses for overall survival (p = .008, .035, .005, and .007, respectively). Conclusion Simultaneous, large‐scale measurement of multiple cytokines may improve NPC detection and prognostic prediction. © 2010 Wiley Periodicals, Inc. Head Neck, 2011Keywords
This publication has 47 references indexed in Scilit:
- Comparison of Multiplex Immunoassay PlatformsClinical Chemistry, 2010
- Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinomaActa Oto-Laryngologica, 2009
- Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinomaOral Oncology, 2008
- Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern ChinaJournal of Translational Medicine, 2008
- Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2006
- The 30-bp Deletion of Epstein-Barr Virus Latent Membrane Protein-1 Gene Has No Effect in Nasopharyngeal CarcinomaThe Laryngoscope, 2006
- Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial CellsNeoplasia, 2006
- Retracted: Transactivation of CCL20 gene by Epstein–Barr virus latent membrane protein 1British Journal of Haematology, 2005
- Expression of the interferon‐inducible chemokine IP‐10 (CXCL10), a chemokine with proposed anti‐neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinomaThe Journal of Pathology, 2005
- Expression of Interleukin-8 Receptor A Predicts Poor Outcome in Patients With Nasopharyngeal CarcinomaThe Laryngoscope, 2005